micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules

Jose L Viñas1, Matthew Spence1, Christopher J Porter2

  • 1Division of Nephrology, Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Kidney International
|June 28, 2021
PubMed

Insights

MicroRNA-486-5p shows therapeutic potential for acute kidney injury (AKI). This study demonstrates that miR-486-5p improves kidney function and reduces injury markers in preclinical models of AKI.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) is a significant clinical challenge with limited effective treatments.
  • MicroRNAs (miRs) are implicated in AKI pathogenesis, but their specific roles and transcriptomic effects remain incompletely understood.
  • Previous work indicated that exosomes enriched with miR-486-5p protected against ischemic AKI in mice.

Purpose of the Study:

  • To investigate the direct therapeutic effects of miR-486-5p in a mouse model of kidney ischemia-reperfusion injury (IRI).
  • To elucidate the impact of miR-486-5p and exosomes on the kidney transcriptome in proximal tubules and endothelial cells following IRI.
  • To determine the molecular mechanisms underlying miR-486-5p's protective effects in AKI.

Main Methods:

  • Utilized a mouse model of kidney ischemia-reperfusion injury (IRI).
  • Administered miR-486-5p mimic to AKI mice and assessed kidney function and histology.
  • Employed RNA-sequencing (RNA-Seq) to compare the transcriptomic changes induced by miR-486-5p and exosomes in isolated proximal tubules and kidney endothelial cells 24 hours post-IRI.
  • Quantified miR-486-5p levels and analyzed downstream signaling pathways, including PTEN/Akt.

Main Results:

  • Injection of miR-486-5p mimic improved plasma creatinine, reduced histological injury, neutrophil infiltration, and apoptosis in AKI mice.
  • miR-486-5p successfully increased its levels in proximal tubules and endothelial cells.
  • miR-486-5p targeted and inhibited phosphatase and tensin homolog (PTEN), leading to activation of protein kinase B (Akt).
  • In proximal tubules, both miR-486-5p and exosomes downregulated genes in the tumor necrosis factor (TNF) pathway and altered apoptotic gene expression.
  • In endothelial cells, miR-486-5p and exosomes modulated genes involved in metabolic processes, but not the TNF pathway.

Conclusions:

  • miR-486-5p demonstrates significant therapeutic potential for mitigating kidney damage in acute kidney injury.
  • The protective effects of miR-486-5p involve the inhibition of PTEN and activation of the Akt pathway.
  • miR-486-5p and exosomes exert distinct transcriptomic effects on kidney proximal tubules and endothelial cells during AKI recovery.